Fluicell
11.40 SEK
0.00 %
Less than 1K followers
FLUI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
0.00 %
+23.91 %
+14.00 %
-4.20 %
-14.29 %
-19.38 %
-95.47 %
-99.61 %
-98.97 %
Fluicell operates in biotechnology. The company conducts research and development in the processing of cell composition in the development of new drugs. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and ultimately process cells. In addition, there is expertise in 2D/3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.
Read moreMarket cap
15.66M SEK
Turnover
4.99K SEK
Revenue
6M
EBIT %
-139.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
8/5
2026
Interim report Q1'26
14/5
2026
General meeting '26
14/8
2026
Interim report Q2'26
All
Press releases
3rd party
ShowingAll content types
Fluicell beviljas patent i EU gällande mikroflödesteknik
Fluicell offentliggör preliminära resultat för fjärde kvartalet 2025 – stärkt nettoomsättning och positivt kassaflöde
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools